Literature DB >> 16616756

A comparison of the NCEP-ATPIII, IDF and AHA/NHLBI metabolic syndrome definitions with relation to early carotid atherosclerosis in subjects with hypercholesterolemia or at risk of CVD: evidence for sex-specific differences.

Michael R Skilton1, Philippe Moulin, André Sérusclat, Patrice Nony, Fabrice Bonnet.   

Abstract

The metabolic syndrome is associated with increased risk of cardiovascular disease. However, the association between metabolic syndrome and atherosclerosis in hypercholesterolemic patients remains unknown. We examined the association between carotid atherosclerosis and metabolic syndrome definitions using the NCEP-ATPIII, International Diabetes Federation (IDF) and American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) definitions in 1782 subjects at risk of cardiovascular disease including 926 with hypercholesterolemia (LDL cholesterol > or =160 mg/dL; mean=203 mg/dL). Irrespective of definition, carotid intima-media thickness was significantly higher in both men and women diagnosed with the MetS compared to those without MetS. This relationship persists in males with hypercholesterolemia, independently of LDL cholesterol level. Regression analyses, both unadjusted and adjusted for traditional risk factors, indicate that in males the AHA/NHLBI definition, and in females the IDF definition are the strongest predictors of carotid atherosclerosis. These results highlight important gender differences that exist in the current clinical definitions of the metabolic syndrome, with regards to predicting early atherosclerotic lesions. In addition, this study shows that in males with hypercholesterolemia, MetS is independently associated with increased atherosclerosis, supporting screening for MetS among people at risk of CVD.

Entities:  

Mesh:

Year:  2006        PMID: 16616756     DOI: 10.1016/j.atherosclerosis.2006.02.019

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  19 in total

1.  Metabolic syndrome as an underlying disease entity and its relationship to subclinical atherosclerosis in Andean Hispanics.

Authors:  Diana A Chirinos; Josefina Medina-Lezama; William Arguelles; Ronald Goldberg; Neil Schneiderman; Zubair Khan; Oscar O Morey; Muhammad Waheed Raja; Roberto Paz; Julio A Chirinos; Maria M Llabre
Journal:  Metab Syndr Relat Disord       Date:  2013-11-08       Impact factor: 1.894

2.  Assessment of oxidative, inflammatory, and fibrinolytic biomarkers and DNA strand breakage in hypercholesterolemia.

Authors:  Renata da Silva Pereira; Etiane Tatsch; Guilherme Vargas Bochi; Helena Kober; Thiago Duarte; Greice Franciele Feyh dos Santos Montagner; José Edson Paz da Silva; Marta Maria Medeiros Frescura Duarte; Ivana Beatrice Mânica da Cruz; Rafael Noal Moresco
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

Review 3.  What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

Authors:  Giovanni Tarantino; Carmine Finelli
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

4.  Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.

Authors:  Todd M Brown; Jenifer H Voeks; Vera Bittner; Monika M Safford
Journal:  Am Heart J       Date:  2010-03       Impact factor: 4.749

5.  Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.

Authors:  O Başar; E Akbal; S Köklü; Y Tuna; E Koçak; N Başar; D Tok; H Erbiş; M Senes
Journal:  Herz       Date:  2013-01-18       Impact factor: 1.443

Review 6.  Managing cardiovascular risk in overweight children and adolescents.

Authors:  Sarita Dhuper; Sujatha Buddhe; Sunil Patel
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

7.  The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study.

Authors:  Angelo Scuteri; Samer S Najjar; Marco Orru'; Gianluca Usala; Maria Grazia Piras; Luigi Ferrucci; Antonio Cao; David Schlessinger; Manuela Uda; Edward G Lakatta
Journal:  Eur Heart J       Date:  2009-11-25       Impact factor: 29.983

8.  Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?

Authors:  Todd M Brown; Dhananjay Vaidya; William J Rogers; David D Waters; Barbara V Howard; Jean-Claude Tardif; Vera Bittner
Journal:  J Womens Health (Larchmt)       Date:  2008-06       Impact factor: 2.681

9.  Self-reported sleep duration is associated with the metabolic syndrome in midlife adults.

Authors:  Martica H Hall; Matthew F Muldoon; J Richard Jennings; Daniel J Buysse; Janine D Flory; Stephen B Manuck
Journal:  Sleep       Date:  2008-05       Impact factor: 5.849

Review 10.  Systematic review and meta-analysis on the adverse events of rimonabant treatment: considerations for its potential use in hepatology.

Authors:  Norberto C Chavez-Tapia; Felix I Tellez-Avila; Giorgio Bedogni; Lory S Crocè; Flora Masutti; Claudio Tiribelli
Journal:  BMC Gastroenterol       Date:  2009-10-09       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.